ArticleCell transplantation

Incidence and Risk Factors Associated with Infection after Chimeric Antigen Receptor T Cell Therapy for Relapsed/Refractory B-cell Malignancies.

Feng Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.